Concepedia

Jessie Wang

JW

Statistics

Publications

33

Citations

2.6K

H-Index

22

Active since

2010

Affiliations

Bristol-Myers Squibb (United States)(Current)

Pfizer (United States)

Analysis Group (United States)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Jessie Wang is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, clinical pharmacology, and medicine.

ORCID

Publications per year

2010–2023

33

Publications

33

Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis

Xiaoli Wang, Giridhar Tirucherai, Thomas Marbury et al. · The Journal of Clinical Pharmacology · 2015 · 284 citations · Full text

, , +17

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

, , +17

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Vijay Upreti, Jessie Wang, Yu Chen Barrett et al. · British Journal of Clinical Pharmacology · 2013 · 269 citations · Full text

, , +17

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Ming Chang, Zhigang Yu, Andrew Shenker et al. · The Journal of Clinical Pharmacology · 2015 · 172 citations

, , +17

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

Jeffrey S. Hyams, Sonia Thomas, Nathan Gotman et al. · The Lancet · 2019 · 166 citations · Full text

, , +13

1–5 of 33